|
|||||
|
|
The effect of needle and syringe program and opioid agonist therapy on the risk of HIV,hepatitis B and C virus infection for people who inject drugs in Amsterdam,the Netherlands: findings from an emulated target trial |
|
| Authors: | Daniela K. van Santen Anders Boyd Amy Matser Lisa Maher Matthew Hickman Sara Lodi Maria Prins |
| Affiliation: | 1. Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands;2. Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands Contribution: Funding acquisition;3. The Kirby Institute for Infection and Immunity, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia;4. Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK;5. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA Contribution: Conceptualization, Methodology, Supervision;6. Department of Infectious Diseases, Research and Prevention, Public Health Service of Amsterdam, Amsterdam, the Netherlands Department of Infectious Diseases, Amsterdam Infection and Immunity Institute (AIandII), Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands Contribution: Conceptualization, Funding acquisition, Supervision |
| Abstract: | |
| Keywords: | harm reduction programs hepatitis B hepatitis C HIV needle and syringe programs opioid agonist therapy people who inject drugs |